Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Move strengthens footprint in Western India and expands multi-specialty care network
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
Subscribe To Our Newsletter & Stay Updated
